Literature DB >> 20866097

Tumor ablation and nanotechnology.

Rachel L Manthe1, Susan P Foy, Nishanth Krishnamurthy, Blanka Sharma, Vinod Labhasetwar.   

Abstract

Next to surgical resection, tumor ablation is a commonly used intervention in the treatment of solid tumors. Tumor ablation methods include thermal therapies, photodynamic therapy, and reactive oxygen species (ROS) producing agents. Thermal therapies induce tumor cell death via thermal energy and include radiofrequency, microwave, high intensity focused ultrasound, and cryoablation. Photodynamic therapy and ROS producing agents cause increased oxidative stress in tumor cells leading to apoptosis. While these therapies are safe and viable alternatives when resection of malignancies is not feasible, they do have associated limitations that prevent their widespread use in clinical applications. To improve the efficacy of these treatments, nanoparticles are being studied in combination with nonsurgical ablation regimens. In addition to better thermal effect on tumor ablation, nanoparticles can deliver anticancer therapeutics that show a synergistic antitumor effect in the presence of heat and can also be imaged to achieve precision in therapy. Understanding the molecular mechanism of nanoparticle-mediated tumor ablation could further help engineer nanoparticles of appropriate composition and properties to synergize the ablation effect. This review aims to explore the various types of nonsurgical tumor ablation methods currently used in cancer treatment and potential improvements by nanotechnology applications.

Entities:  

Mesh:

Year:  2010        PMID: 20866097      PMCID: PMC2997921          DOI: 10.1021/mp1001944

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  157 in total

Review 1.  Nanoparticles in photodynamic therapy: an emerging paradigm.

Authors:  Dev Kumar Chatterjee; Li Shan Fong; Yong Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

2.  Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells--a possible Trojan strategy against cancer.

Authors:  Xiaolin Li; Donghui Zhen; Xiaowei Lu; Hua'e Xu; Yun Shao; Qiping Xue; Yong Hu; Baorui Liu; Weihao Sun
Journal:  Eur J Pharm Biopharm       Date:  2010-05-11       Impact factor: 5.571

3.  The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma.

Authors:  Monica Camerin; Michela Magaraggia; Marina Soncin; Giulio Jori; Miguel Moreno; Isabelle Chambrier; Michael J Cook; David A Russell
Journal:  Eur J Cancer       Date:  2010-03-29       Impact factor: 9.162

4.  Pharmacokinetics and excretion of dalbavancin in the rat.

Authors:  Marco Cavaleri; Simona Riva; Anna Valagussa; Marco Guanci; Luigi Colombo; James Dowell; Martin Stogniew
Journal:  J Antimicrob Chemother       Date:  2005-03       Impact factor: 5.790

Review 5.  The emerging role of reactive oxygen species in cancer therapy.

Authors:  Markus F Renschler
Journal:  Eur J Cancer       Date:  2004-09       Impact factor: 9.162

6.  Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.

Authors:  Jun-Jie Yin; Fang Lao; Jie Meng; Peter P Fu; Yuliang Zhao; Gengmei Xing; Xueyun Gao; Baoyun Sun; Paul C Wang; Chunying Chen; Xing-Jie Liang
Journal:  Mol Pharmacol       Date:  2008-07-17       Impact factor: 4.436

7.  Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes.

Authors:  Omar R El Hayek; Wladimir Alfer; Ernesto Reggio; Antonio Carlos L Pompeo; Sami Arap; Antonio Marmo Lucon; Miguel Srougi
Journal:  Urol Int       Date:  2008-08-29       Impact factor: 2.089

Review 8.  Curability of cancer by radiotherapy and chemotherapy, including in neuraxial neoplasms.

Authors:  Rakesh Jalali; Anusheel Munshi; Brijesh Arora
Journal:  Neurol India       Date:  2009 Jan-Feb       Impact factor: 2.117

9.  Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.

Authors:  Darya Alizadeh; Leying Zhang; Jungyeon Hwang; Thomas Schluep; Behnam Badie
Journal:  Nanomedicine       Date:  2009-11-05       Impact factor: 5.307

10.  Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.

Authors:  Patrick L Apopa; Yong Qian; Rong Shao; Nancy Lan Guo; Diane Schwegler-Berry; Maricica Pacurari; Dale Porter; Xianglin Shi; Val Vallyathan; Vincent Castranova; Daniel C Flynn
Journal:  Part Fibre Toxicol       Date:  2009-01-09       Impact factor: 9.400

View more
  26 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  Anticancer agents: Unleash the forces within.

Authors:  Weiwei Gao; Liangfang Zhang
Journal:  Nat Chem       Date:  2012-12       Impact factor: 24.427

Review 3.  Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.

Authors:  Rochelle R Arvizo; Sanjib Bhattacharyya; Rachel A Kudgus; Karuna Giri; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

4.  Understanding Acoustic Cavitation Initiation by Porous Nanoparticles: Toward Nanoscale Agents for Ultrasound Imaging and Therapy.

Authors:  Adem Yildirim; Rajarshi Chattaraj; Nicholas T Blum; Andrew P Goodwin
Journal:  Chem Mater       Date:  2016-08-09       Impact factor: 9.811

5.  Phospholipid Capped Mesoporous Nanoparticles for Targeted High Intensity Focused Ultrasound Ablation.

Authors:  Adem Yildirim; Rajarshi Chattaraj; Nicholas T Blum; Dennis Shi; Kaushlendra Kumar; Andrew P Goodwin
Journal:  Adv Healthc Mater       Date:  2017-07-12       Impact factor: 9.933

Review 6.  Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.

Authors:  Beth Goins; William T Phillips; Ande Bao
Journal:  Expert Opin Drug Deliv       Date:  2016-04-04       Impact factor: 6.648

7.  Anti-tumor Efficacy Study using Irreversible Electroporation and Doxorubicin-loaded Polymeric Micelles.

Authors:  Jun Zhao; John Qiao; Min Zhou; Sanjay Gupta; Chun Li; Marites P Melancon
Journal:  ACS Macro Lett       Date:  2015-09-11       Impact factor: 6.903

8.  Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection.

Authors:  Xiaohui Zheng; Feifan Zhou; Baoyan Wu; Wei R Chen; Da Xing
Journal:  Mol Pharm       Date:  2012-02-22       Impact factor: 4.939

Review 9.  Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

Authors:  William T Phillips; Ande Bao; Andrew J Brenner; Beth A Goins
Journal:  Adv Drug Deliv Rev       Date:  2014-07-09       Impact factor: 15.470

Review 10.  Computational modelling of microwave tumour ablations.

Authors:  Jason Chiang; Peng Wang; Christopher L Brace
Journal:  Int J Hyperthermia       Date:  2013-06       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.